Physician profile
John J Grillo
NPI 1104919265
$4,917.35
in general payments reported to CMS, 2019-2025
24 companies · $719 in 2025
The $719 reported for 2025 was more than what 93% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,056 · 2020: $236 · 2021: $816 · 2022: $615 · 2023: $560 · 2024: $915 · 2025: $719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,194.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,666.47 | 2019-2025 | Xifaxan |
| Qol Medical, LLC | $964.22 | 2021-2025 | Sucraid, Sucraid |
| Takeda Pharmaceuticals U.S.A., INC. | $894.02 | 2020-2025 | Entyvio |
| Ucb, INC. | $401.03 | 2019-2020 | |
| Shire North American Group INC | $244.82 | 2019 | |
| Janssen Biotech, INC. | $136.68 | 2019-2024 | Stelara |
| Abbvie INC. | $110.08 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.14 | 2023-2024 | Jardiance, Cyltezo |
| Pfizer INC. | $56.22 | 2021 | |
| Sandoz INC. | $44.55 | 2023-2024 | Hyrimoz |
| Acelrx Pharmaceuticals, INC. | $33.32 | 2021 | |
| Lilly USA, LLC | $31.94 | 2025 | Omvoh |
| Intercept Pharmaceuticals, INC. | $28.36 | 2019-2020 | |
| Boston Scientific Corporation | $24.25 | 2022 | |
| Sobi, INC | $24.02 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $23.85 | 2023 | Cologuard Collection Kit |
| Allergan, INC. | $22.83 | 2019 | |
| Braintree Laboratories, INC. | $19.63 | 2019 | |
| Endo Pharmaceuticals INC. | $17.92 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.42 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $16.26 | 2020 | |
| Oxford Immunotec USA INC | $15.95 | 2022 | |
| Glaxosmithkline, LLC. | $15.87 | 2021 | |
| Merck Sharp & Dohme LLC | $15.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Grillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.